Literature DB >> 29259099

IL-2Rβ abundance differentially tunes IL-2 signaling dynamics in CD4+ and CD8+ T cells.

Geoffrey A Smith1,2, Jack Taunton1, Arthur Weiss3,4.   

Abstract

Interleukin-2 (IL-2) stimulates both activated CD4+ and CD8+ T cells to proliferate. IL-2 signals through an identical receptor complex and promotes the same dose-dependent phosphorylation of the canonical transcription factor STAT5 in both cell types. Despite this, CD8+ T cells enter the S phase earlier and proliferate to a greater extent than do CD4+ T cells in response to IL-2. We identified distinct IL-2 signaling dynamics in CD4+ and CD8+ T cells. In IL-2-stimulated CD8+ T cells, STAT5 phosphorylation increased rapidly and was sustained for 6 hours. In contrast, CD4+ T cells had a biphasic response, with maxima at 15 min and 2 to 4 hours after stimulation. Both cell types required vesicular trafficking, but only CD4+ T cells required new protein synthesis to maintain high phosphorylation of STAT5. Two subunits of the IL-2 receptor, IL-2Rβ and IL-2Rγ, were twice as abundant in CD8+ T cells than in CD4+ T cells. Reduction of IL-2Rβ abundance by 50% was sufficient to convert CD8+ T cells to a CD4+ T cell-like signaling pattern and delay S phase entry. These results suggest that the larger pool of IL-2Rβ chains in CD8+ T cells is required to sustain IL-2 signaling and contributes to the quantitatively greater proliferative response to IL-2 relative to that of CD4+ T cells. This cell type-specific difference in IL-2Rβ abundance appears to tune responses, potentially preventing extensive, autoimmune proliferation of CD4+ T cells, while still enabling sufficient proliferation of CD8+ T cells to control viral infections.
Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29259099      PMCID: PMC5741096          DOI: 10.1126/scisignal.aan4931

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  36 in total

1.  Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection.

Authors:  Rob J De Boer; Dirk Homann; Alan S Perelson
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

2.  IL-2 Modulates the TCR Signaling Threshold for CD8 but Not CD4 T Cell Proliferation on a Single-Cell Level.

Authors:  Byron B Au-Yeung; Geoffrey Alexander Smith; James L Mueller; Cheryl S Heyn; Rebecca Garrett Jaszczak; Arthur Weiss; Julie Zikherman
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

Review 3.  The role of interleukin-2 during homeostasis and activation of the immune system.

Authors:  Onur Boyman; Jonathan Sprent
Journal:  Nat Rev Immunol       Date:  2012-02-17       Impact factor: 53.106

4.  Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: a fluorescence resonance energy transfer study.

Authors:  S Damjanovich; L Bene; J Matkó; A Alileche; C K Goldman; S Sharrow; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Ligand binding analysis of soluble interleukin-2 receptor complexes by surface plasmon resonance.

Authors:  Z Wu; K W Johnson; Y Choi; T L Ciardelli
Journal:  J Biol Chem       Date:  1995-07-07       Impact factor: 5.157

6.  EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor.

Authors:  S Traverse; K Seedorf; H Paterson; C J Marshall; P Cohen; A Ullrich
Journal:  Curr Biol       Date:  1994-08-01       Impact factor: 10.834

7.  Analysis of the role of the interleukin-2 receptor gamma chain in ligand binding.

Authors:  Stefano F Liparoto; David G Myszka; Zining Wu; Byron Goldstein; Thomas M Laue; Thomas L Ciardelli
Journal:  Biochemistry       Date:  2002-02-26       Impact factor: 3.162

8.  Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function.

Authors:  Jian-Xin Lin; Peng Li; Delong Liu; Hyun Tak Jin; Jianping He; Mohammed Ata Ur Rasheed; Yrina Rochman; Lu Wang; Kairong Cui; Chengyu Liu; Brian L Kelsall; Rafi Ahmed; Warren J Leonard
Journal:  Immunity       Date:  2012-04-20       Impact factor: 31.745

9.  Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments.

Authors:  Dorothea Busse; Maurus de la Rosa; Kirstin Hobiger; Kevin Thurley; Michael Flossdorf; Alexander Scheffold; Thomas Höfer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-28       Impact factor: 11.205

10.  A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration.

Authors:  Leon O Murphy; Jeffrey P MacKeigan; John Blenis
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

View more
  5 in total

1.  Regulatory T Cells Maintain Selective Access to IL-2 and Immune Homeostasis despite Substantially Reduced CD25 Function.

Authors:  Erika T Hayes; Cassidy E Hagan; Liliane Khoryati; Marc A Gavin; Daniel J Campbell
Journal:  J Immunol       Date:  2020-10-14       Impact factor: 5.422

Review 2.  The perception and response of T cells to a changing environment are based on the law of initial value.

Authors:  Eric S Huseby; Emma Teixeiro
Journal:  Sci Signal       Date:  2022-05-31       Impact factor: 9.517

3.  Functional Change of Effector Tumor-Infiltrating CCR5+CD38+HLA-DR+CD8+ T Cells in Glioma Microenvironment.

Authors:  Pin-Yuan Chen; Caren Yu-Ju Wu; Jian-He Fang; Hsiu-Chi Chen; Li-Ying Feng; Chiung-Yin Huang; Kuo-Chen Wei; Jia-You Fang; Chun-Yen Lin
Journal:  Front Immunol       Date:  2019-10-09       Impact factor: 7.561

4.  T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice.

Authors:  Genevieve N Mullins; Kristen M Valentine; Mufadhal Al-Kuhlani; Dan Davini; Kirk D C Jensen; Katrina K Hoyer
Journal:  Sci Rep       Date:  2020-12-15       Impact factor: 4.379

5.  Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.

Authors:  Janna Krueger; Francois Santinon; Alexandra Kazanova; Mark E Issa; Bruno Larrivee; Richard Kremer; Catalin Milhalcioiu; Christopher E Rudd
Journal:  PLoS One       Date:  2021-06-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.